Referral Guidelines

Information for Referring Physicians

Verspeeten Family Cancer Centre has a different referral process than other Ontario cancer centres. Our policy is to discuss treatment options during the patient’s first visit with the oncologist.

In order for the oncologist to make treatment decisions at the first appointment, all medical workups and tests need to be completed prior. The oncologist will need the results of these tests in order to design the treatment that is best for your patient’s type of cancer.

Since cancer is different in every patient, the type of tests and examinations that must be completed will vary. Please refer to the Intake Guidelines below to determine the type of information that we need from you, as a healthcare provider, in order to properly process incoming patients at Verspeeten Family Cancer Centre.

• Download the Verspeeten Family Care Centre New Patient Referral Form
• Download the CLIPS and Baker Centre Referral Form
• Download the Regional Skin Cancer Referral Form
• Download (formerly) LRCP Disease Specific Referral Guidelines

Rapid Response Clinic (Palliative Radiotherapy):

• View the Guide for Referring Physicians & Healthcare Providers
• View the Guide for Inpatient Care Teams and Regional Hospitals

Radioligand Therapy Program

The Radioligand Therapy Program currently offers Pluvicto® (177Lu vipivotide tetraxetan) for eligible patients with prostate cancer and Lutathera (177Lu oxodotreotide) for eligible patients with neuroendocrine tumours, in accordance with established clinical criteria.

Referrals for radioligand therapy must be submitted directly to the Department of Medical Imaging and Theranostics (MIT).

• Fax: 1‑519‑667‑6734
• Email: PLUVICTO@lhsc.on.ca for Pluvicto therapies
• Email: radionuclidetherapy@lhsc.on.ca for Lutathera therapies

Electronic referrals: Documents containing personal health information (PHI) must be transmitted using secure, privacy‑approved platforms (e.g., FileSafe). Unencrypted external email should not be used for referral submissions containing PHI.

For Lutathera Referrals: Download the New Patient Referral Form Select "Nuclear Oncology".

For Pluvicto Referrals: Download the Pluvicto Referral Form. 

Intake Guidelines by Disease Site

The following guidelines are flowcharts in Adobe Acrobat PDF format. They outline what tests are needed for patient processing and initial appointment booking at the Verspeeten Family Cancer Centre.